Recent placebo controlled pharmaceutical industry SERM trials have demonstrated short term safety and efficacy in men with secondary hypogonadism and eventually might provide an alternative to exogenous testosterone replacement therapy in men with secondary hypogonadism doxycycline treats
Questions & Answers
There are no questions yet for this shipment. Be the first to ask one!
Carriers Bidding
There are no carriers bidding for this shipment yet. Be the first to bid!